- Letters to the Editor Functional cure of CHB encounters resmetirom
- Nai-Bin Yang, Wai-Kay Seto, Ming-Hua Zheng
- DOI: 10.3350/cmh.2024.0301 [Epub ahead of print]
- Reviews MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31.
- Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
- Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
- Clin Mol Hepatol. 2022;28(4):725-738.
- Original Articles Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients
- Wen-Yue Liu, Xiaofang Zhang, Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Rafael S. Rios, Kenneth I. Zheng, Hong-Lei Ma, Xiao-Dong Wang, Qiuwei Pan, Robert J. de Knegt, Luca Valenti, Mohsen Ghanbari, Ming-Hua Zheng
- Clin Mol Hepatol. 2022;28(2):183-195.
- Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
- Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding
- Clin Mol Hepatol. 2021;27(2):329-345.